Income Statement
FORTRESS BIOTECH, INC.
FBIO
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
63.26 | 57.68 | 84.51 | 75.74 | 68.79 | 45.60 | 36.63 | 26.88 | 187.58 | 16.48 | 0.86 | - | - | - | - |
|
Cost of Revenue
|
20.92 | 20.88 | 26.66 | 30.78 | 32.08 | 14.59 | 10.53 | 6.13 | - | - | - | - | - | - | - |
|
Gross Profit
|
42.34 | 36.80 | 57.85 | 44.97 | 36.71 | 31.01 | 26.10 | 20.76 | 187.58 | 16.48 | 0.86 | - | - | - | - |
|
Operating Expenses
|
96.40 | 87.73 | 94.12 | 113.66 | 86.84 | 61.17 | 55.59 | 146.88 | 288.79 | 82.19 | 51.39 | 20.65 | 35.78 | 26.13 | 14.34 |
|
Research & Development
|
11.90 | 56.63 | 101.75 | 134.20 | 113.24 | 2.83 | 75.24 | 87.38 | 52.49 | 29.60 | 18.40 | 10.24 | 25.68 | 17.47 | 8.58 |
|
Selling, General & Administrative
|
96.40 | 87.73 | 94.12 | 113.66 | 86.84 | 61.17 | 55.59 | 53.37 | 50.90 | 34.00 | 21.58 | 10.41 | 10.10 | 8.67 | 5.76 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-54.06 | -50.94 | -36.27 | -68.69 | -50.14 | -30.16 | -29.49 | -126.12 | -101.21 | -65.71 | -50.53 | -20.65 | -35.78 | -26.13 | -14.34 |
|
Non-Operating Income
|
39.26 | 0.49 | -1.56 | -2.05 | 31.67 | -0.70 | 9.16 | -10.80 | 2.89 | -5.58 | -3.35 | - | - | - | - |
|
Interest Income
|
2.49 | 2.68 | 3.00 | 1.40 | 0.65 | 1.52 | 2.56 | 1.10 | 2.76 | 0.30 | 0.25 | 0.66 | 0.55 | 0.24 | 0.17 |
|
Interest Expense
|
10.11 | 13.53 | 15.32 | 12.48 | 15.31 | 15.33 | - | - | 5.86 | 3.69 | 1.50 | 15.00 | 1.92 | 0.67 | 0.07 |
|
Other Non-Op Income / Expense
|
17.67 | 1.32 | -3.40 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
20.76 | -11.70 | -153.63 | -213.46 | -164.35 | -102.85 | -101.66 | -130.80 | -98.32 | - | - | - | - | - | - |
|
Income Tax Expense
|
-40.35 | -74.55 | -93.00 | -126.89 | -99.65 | -56.32 | -101.66 | -130.80 | -98.32 | - | - | - | - | - | - |
|
Non-Controlling Interest
|
-39.73 | -74.86 | -93.52 | 0.00 | 0.00 | 0.49 | 0.33 | 57.79 | 0.01 | 0.00 | 0.00 | - | - | - | - |
|
Net Income
|
6.82 | -46.00 | -60.64 | -86.58 | -64.70 | -46.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -20.39 | 0.00 | -27.61 | -36.36 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-54.06 | -50.94 | -36.27 | -68.69 | -50.14 | -30.16 | -29.49 | -126.12 | -99.12 | -65.17 | -50.51 | -20.65 | -35.78 | -26.13 | -14.34 |
|
Earnings Per Share (Basic)
|
-0.07 | -2.69 | -8.47 | -0.97 | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-0.07 | -2.69 | -8.47 | -0.97 | - | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
27.90 | 20.78 | 8.11 | 88.87 | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
27.90 | 20.78 | 8.11 | 88.87 | - | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |